4.1 Saudi Regional Infections (MERS-CoV, Brucellosis, TB, Dengue) & Antimicrobial Therapy

Introduction to Endemic Infections in Saudi Arabia

The geographic, cultural, and environmental landscape of Saudi Arabia creates a unique infectious disease profile. Familiarity with these endemic conditions is paramount for medical practitioners and is heavily tested on the SMLE. Key diseases include Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Brucellosis, Dengue fever, and Tuberculosis (TB). The immense annual gathering of Hajj also introduces unique public health challenges, notably the risk of Neisseria meningitidis outbreaks, which mandates strict pre-arrival vaccination policies. Additionally, due to rising rates of antimicrobial resistance globally and locally, understanding local antimicrobial stewardship guidelines is absolutely critical for all practicing physicians.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Epidemiology and Transmission MERS-CoV is a highly lethal zoonotic viral respiratory illness first reported in Saudi Arabia in 2012. Dromedary camels are the well-established primary animal reservoir. Human-to-human transmission does not occur easily in community settings but happens readily in healthcare settings through close contact with infected individuals, necessitating strict airborne and contact isolation precautions for all suspected cases. Healthcare workers must remain vigilant during triage.

Clinical Presentation The clinical spectrum ranges from asymptomatic infection to severe acute respiratory distress syndrome (ARDS) and multi-organ failure. Typical symptoms include a high, unremitting fever, dry cough, progressively worsening shortness of breath, and severe myalgia. Gastrointestinal symptoms, such as diarrhea, nausea, and vomiting, are surprisingly common early in the course. Patients with underlying medical comorbidities—especially uncontrolled diabetes mellitus, end-stage renal disease, chronic lung disease, and immunosuppression—are at the highest risk for severe, life-threatening disease.

Diagnosis and Management Diagnosis is confirmed via real-time reverse transcription polymerase chain reaction (rRT-PCR) of respiratory tract secretions. Lower respiratory tract specimens (e.g., bronchoalveolar lavage, tracheal aspirates, or induced sputum) have significantly higher viral loads and yield better diagnostic accuracy than standard nasopharyngeal swabs, which can yield false negatives. Management is entirely supportive, focusing on protective mechanical ventilation strategies for ARDS and extracorporeal membrane oxygenation (ECMO) in refractory hypoxemic cases. Despite numerous clinical trials, there are currently no universally approved targeted antiviral therapies, though agents like Remdesivir have been explored.

Brucellosis (Undulant Fever)

Epidemiology and Presentation Brucellosis remains a highly prevalent zoonotic infection in Saudi Arabia, primarily transmitted through the consumption of unpasteurized (raw) dairy products or direct occupational contact with infected livestock such as sheep, goats, and camels. Brucella melitensis is the most common and most virulent species globally.

Patients typically present with an insidious onset of "undulant" (waxing and waning) fever, profuse drenching night sweats, profound fatigue, weight loss, and diffuse arthralgia. Osteoarticular involvement is the most common focal complication, frequently presenting as sacroiliitis or spondylodiscitis (most commonly involving the lumbar spine). Other significant complications include epididymo-orchitis in males, neurobrucellosis (meningitis or encephalitis), and endocarditis. Brucella endocarditis often involves the aortic valve and is the leading cause of brucellosis-related mortality.

Diagnosis and Management Diagnosis involves blood cultures, which must be held for extended periods (up to 21 days) as the organism is fastidious and slow-growing. Serological testing is more commonly used; the Standard Tube Agglutination (STA) test is standard, with titers >1:160 generally considered positive in endemic areas. Treatment strictly requires combination, prolonged antibiotic therapy to prevent high rates of relapse. The standard regimen for uncomplicated brucellosis in non-pregnant adults is Doxycycline (for a minimum of 6 weeks) combined with either Rifampin (for 6 weeks) or an Aminoglycoside (e.g., Streptomycin or Gentamicin for the first 2-3 weeks). Pregnant women and children under 8 years of age are typically treated with alternative regimens, such as Trimethoprim-Sulfamethoxazole and Rifampin, to avoid doxycycline-induced tooth discoloration and teratogenicity.

Dengue Fever and Malaria Considerations

Dengue Fever Epidemiology and Presentation Dengue is a mosquito-borne arboviral infection transmitted primarily by the Aedes aegypti mosquito, which bites during the daytime. In Saudi Arabia, it is highly endemic in the western and southern coastal regions, notably Jeddah, Makkah, and Jazan. The clinical course consists of three distinct phases: febrile, critical, and recovery.

The initial febrile phase features sudden high fever, severe frontal headache, intense retro-orbital pain, severe myalgias and deep bone pain (classically termed "breakbone fever"), a generalized maculopapular rash, and a positive tourniquet test indicating capillary fragility. The critical phase begins around days 3 to 7, precisely when the fever breaks (defervescence). This phase is characterized by a dangerous increase in systemic capillary permeability, leading to plasma leakage, ascites, pleural effusions, profound hemoconcentration (indicated by a rising hematocrit), and severe thrombocytopenia. If unmanaged, this rapidly progresses to Dengue Shock Syndrome (DSS) and severe hemorrhagic manifestations.

Diagnosis and Management Early diagnosis (during days 1-5 of illness) relies on detecting the Dengue NS1 antigen or viral RNA via PCR. After day 5, the immune response takes over, and IgM and IgG serology become the primary diagnostic modalities. Management is strictly and aggressively supportive. Fluid management is the absolute cornerstone of therapy; judicious intravenous crystalloids are required during the critical phase to counteract plasma leakage while carefully avoiding fluid overload in the subsequent recovery phase, when extravasated fluid shifts back into the intravascular space. NSAIDs (like Ibuprofen) and Aspirin are strictly contraindicated due to the severe risk of exacerbating bleeding and causing Reye syndrome in pediatric patients.

Malaria Note: While malaria has been largely eliminated in much of the Kingdom, cases (predominantly Plasmodium falciparum) still occur in the southern border regions (Jazan, Asir). It must remain on the differential for any febrile illness with a travel history to these areas or international endemic zones. Diagnosis is via thick and thin peripheral blood smears.

Tuberculosis (TB)

Epidemiology and Presentation Saudi Arabia has a moderate overall burden of TB, heavily influenced by a large expatriate workforce arriving from highly endemic regions (e.g., South Asia, Southeast Asia, Sub-Saharan Africa) and the mass gatherings during Hajj. Mycobacterium tuberculosis is strictly transmitted via airborne droplet nuclei. Primary pulmonary TB is often entirely asymptomatic or causes a mild, self-limiting fever and the formation of calcified Ghon complexes. Reactivation (secondary) TB classically presents with a chronic, insidious productive cough, hemoptysis, drenching night sweats, low-grade afternoon fever, and unintended weight loss. Reactivation almost exclusively involves the highly oxygenated apices of the lungs, forming classic cavitary lesions.

Diagnosis and Management Diagnosis hinges on the sputum acid-fast bacilli (AFB) smear, mycobacterial culture (the gold standard, though it takes weeks), and the increasingly utilized GeneXpert MTB/RIF assay. GeneXpert is revolutionary as it rapidly detects the mycobacterial DNA and simultaneously identifies rifampin resistance mutations within hours. Latent TB infection (LTBI) is screened using the Tuberculin Skin Test (TST/PPD) or the more specific Interferon-Gamma Release Assay (IGRA).

Active TB treatment employs the intensive RIPE regimen (Rifampin, Isoniazid, Pyrazinamide, Ethambutol) for 2 months, followed by a continuation phase of Rifampin and Isoniazid for an additional 4 months (6 months total for standard pulmonary TB). Key medication side effects to meticulously monitor: Rifampin (benign orange discoloration of bodily fluids, potent CYP450 induction), Isoniazid (peripheral neuropathy, which is prevented by co-administering Vitamin B6 / Pyridoxine, and hepatotoxicity), Pyrazinamide (hyperuricemia and severe, dose-dependent hepatotoxicity), and Ethambutol (retrobulbar optic neuritis causing decreased visual acuity and red-green color blindness).

Antimicrobial Stewardship in Saudi Arabia

The Ministry of Health (MOH) and Saudi Food and Drug Authority (SFDA) have enacted stringent regulations that strictly prohibit the dispensing of systemic antibiotics without a valid prescription by a licensed physician. This proactive policy combats the alarming global and local rise in multi-drug resistant organisms (MDROs) such as Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococci (VRE), and Carbapenem-Resistant Enterobacteriaceae (CRE). First-line empirical therapies must closely adhere to regularly updated local hospital antibiograms. Furthermore, broad-spectrum agents (e.g., Meropenem, Piperacillin-Tazobactam) are typically restricted to severe, life-threatening hospital-acquired infections or when explicitly guided by culture sensitivities, often requiring pre-approval from an infectious disease specialist.

Comparative Table: Endemic Febrile Illnesses